In many solid tumors, including NSCLC, the assessment of PD-L1 expression on the surface of tumor cells is recognized to be a highly significant predictive factor for the effectiveness of immunotherapy with PD-1 inhibitors.
1
—
—
In many solid tumors, including NSCLC, the assessment of PD-L1 expression on the surface of tumor cells is recognized to be a highly significant predictive factor for the effectiveness of immunotherapy with PD-1 inhibitors.